HeartWare International, Inc.
(formerly known as HeartWare Limited)
Announcements / Press Releases
Please download the latest "Acrobat Reader" to view the PDF.
| Cancellation of Employee Share Options (in PDF) | |
| Mark Slaughter, M.D. Appointed Principal Investigator of HeartWare Clinical Trial (in PDF) | |
| Successful Completion of International Clinical Trial 50 Patients Enrolled (in PDF) | |
| HeartWare International Files for NASDAQ Listing (in PDF) | |
| Second HeartWare Implant in U.S. - First in Kentucky at Jewish Hopsital, Louisville (in PDF) | |
| Presentations at Forthcoming Conferences (in PDF) | |
| Appendix 3X - Initial Director's Interest Notice (in PDF) | |
| HeartWare Group Redomiciliation & Trading of CDIs (in PDF) | |
| Certificate of Incorporation of HeartWare International, Inc. (in PDF) | |
| Bylaws of HeartWare International, Inc. (in PDF) | |
| Date of Allotment of CDIs and Despatch of Holding Statements (in PDF) | |
| HeartWare International, Inc Indicative Distribution Schedule (in PDF) | |
| HeartWare International, Inc Indicative Top 20 CDI Holders (in PDF) | |
| Admission of HeartWare International, Inc to Official List of ASX (in PDF) | |
| Lodgement of Court Orders with ASIC (in PDF) | |
| Quarterly Update and Appendix 4C (in PDF) | |
| HeartWare Receives Federal Court Approval for Schemes of Arrangement (in PDF) | |
| Results of Meetings (in PDF) | |
| Chairman's Script for the Meetings of Shareholders and Incentive Holders Pursuant to the Information Memorandum Dated 12 September 2008 (in PDF) | |
| HeartWare Awarded ISO Certification (in PDF) | |
| Presentations at Forthcoming Medical Conferences (in PDF) | |
| Appendix 3X - Initial Director's Interest Notice (in PDF) | |
| HeartWare Appoints Ray Larkin Jr. to Board of Directors (in PDF) | |
| Cancellation of Employee Share Options (in PDF) | |
| US FDA Grants Full Approval of HeartWare's IDE (in PDF) | |
| Redomiciliation Documents Dispatched to Shareholders (in PDF) | |
| Australian Federal Court Orders Scheme Meetings to Vote on Proposed Redomiciliation of the HeartWare Group from Australia to the United States of America (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| HeartWare Files for CE Mark for the HeartWare® Left Ventricular Assist System (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Change of Share Registry (in PDF) | |
| Cancellation of Employee Share Options (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Correction of Directors' Interests (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| First US Implant of the HeartWare® Left Ventricular Assist System (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Annual Equity Award (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Half-Year Report for the Period Ended 30 June 2008 Provided Pursuant to ASX Listing Rule 4.2A. (in PDF) | |
| HeartWare Presentation at Canaccord Adams Global Growth Conference (in PDF) | |
| HeartWare Announces Proposed Redomiciliation of the HeartWare Group in the United States (in PDF) | |
| First IRB Approval in the United States (in PDF) | |
| Quarterly Update and Appendix 4C (in PDF) | |
| Redemption of Apple Tree Partners Convertible Note (in PDF) | |
| Issue of Ordinary Shares to Non-Executive Directors Pursuant to Private Placement (in PDF) | |
| Issue of Options to Non-Executive Director - Mr Tim Barberich (in PDF) | |
| Completion of Private Placement to Raise Approx. A$31 million (in PDF) | |
| Results of Extraordinary General Meeting (in PDF) | |
| Cancellation of Options (in PDF) | |
| Cancellation of Shareholder Share Purchase Plan (in PDF) | |
| Notice of Extraordinary General Meeting (in PDF) | |
| Shareholder Share Purchase Plan Update (in PDF) | |
| Preliminary Notice of Meeting - EGM (in PDF) | |
| HeartWare Raises in Excess of AU$30M in Private Share Placement (in PDF) | |
| Operational Update (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Issue of Performance Rights to Chief Executive Officer & Executive Director - Mr Douglas Godshall (in PDF) | |
| Results of Annual General Meeting (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| HeartWare Receives Conditional Approval of IDE (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) | |
| HeartWare Appoints Timothy J. Barberich to Board of Directors (in PDF) | |
| HeartWare Appoints David R. Hathaway, M.D. Chief Medical Officer (in PDF) | |
| HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility (in PDF) | |
| Change in Substantial Holding (in PDF) | |
| Notice of Annual General Meeting 2008 (in PDF) | |
| Cancellation of Employee Share Options (in PDF) | |
| Draft Notice of Annual General Meeting (in PDF) | |
| Notice of Change of Interests of Substantial Holding (in PDF) | |
| Ceasing to be a Substantial Holder (in PDF) | |
| Enrollment of 30th Patient in International Clinical Trial (in PDF) | |
| Annual Financial Report & Directors' Report (in PDF) | |
| Results for Announcement to the Market - ASX Appendix 4E - Preliminary Final Report for the 12 Months Ended 31 December 2007 (in PDF) | |
| Form 10-K (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) | |
| 2009 Announcements / Press Releases | |
| 2007 Announcements / Press Releases | |
| 2006 Announcements / Press Releases | |
| 2005 Announcements / Press Releases |
| DISCLAIMER: irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website. |